• Create BookmarkCreate Bookmark
  • Create Note or TagCreate Note or Tag
  • PrintPrint
Share this Page URL
Help

Chapter 4. Finding Your Flow > The Value of Flow Structures

The Value of Flow Structures

Dr. Emile Loria was the CEO of a French biotechnology company called BioVector Therapeutics, whose science was drug delivery through inhalants. Emile worked diligently with me, over many sessions, to develop the BioVector IPO road show. However, as often happens, the company was acquired instead of going public. Emile then became the CEO of an already-public U.S. biotechnology company called Epimmune, whose science was based on a naturally occurring substance called epitopes. Epimmune had harnessed epitopes to create vaccines to help the body's immune system fight cancer and infectious diseases.

Emile asked me to review the Epimmune presentation that he was scheduled to deliver at a biotechnology conference the following week. I received a copy of his presentation via email at home over a dial-up line, so it took about fifteen minutes to download the image-rich file. I first looked at his overview slide (Figure 4.3).


PREVIEW

                                                                          

Not a subscriber?

Start A Free Trial


  
  • Creative Edge
  • Create BookmarkCreate Bookmark
  • Create Note or TagCreate Note or Tag
  • PrintPrint